Saksena S, Yang X, Khosravi-Hafshejani T, Jun S, Wei E, Eldaboush A, Almeida Gomes LL, Feng R, Werth VP Prednisone dosage is the primary modifiable risk factor for infection in pemphigus with rituximab treatment: A retrospective analysis of 105 patients. J Am Acad Dermato , J Am Acad Dermatol, 95(4): 2026,1208-1211
Arkin LM, Buhr KA, Ardoin SP, Faith EF, Lee LW, von Scheven E, Brandling-Bennett JH, Castelo-Soccio L, Chiu YE, Diaz LZ, Garcia-Romero MT, Hunt RD, Oza VS, Schoch JJ, Paller AS, Vleugels RA, Chong BF, Werth VP, Ardalan K; CARRA-PeDRA Lupus Dermatology Work Groups Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study , J Am Acad Dermatol, 95(4): 2026,1011-1019
Jun S, Gross N, Wei E, Saksena S, Eldaboush A, Homer RO, Almeida Gomes LL, Khosravi-Hafshejani T, Ali H, Werth VP The association between family history of autoimmunity, herbal supplement use, and disease activity in dermatomyositis: A retrospective analysis , J Am Acad Dermatol, 95(2): 2026,566-568
Glen Aldrix R. Anarna, MD, Hanna Lucero-Orillaza, MD, Geraldine T. Zamora, MD, Blessie Marie B. Perez, MD, Victoria P. Werth, MD, Josef Symon S. Concha, MD Evaluation of the Applicability of the Cutaneous Lupus Erythematosus Area and Severity Index (CLASI) in Filipino Cutaneous Lupus Erythematosus Patients , JAAD Int, 27: 2026
Merola JF, Werth VP, Choi JC, Becker B, Edwards T, Hobar C, Pomponi S, Eliason L, Strand V Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms , Lupus Sci Med, 13(2): 2026
Han HS, Kulkarni R, Sollecito TP, Werth VP, Stoopler ET Beyond 1993: A Case Illustrating the 2021 Revised Criteria for Paraneoplastic Autoimmune Multiorgan Syndrome , Int J Dermatol: 2026
Jun S, Xie L, Lopes Almeida Gomes L, Saksena S, Wei E, Stone CJ, Forman Faden D, Yang X, Eldaboush A, Werth VP Postural Orthostatic Tachycardia Syndrome and Dermatomyositis , JAMA Dermatol, 162(9): 2026,960-963
Morand EF, Werth VP, Wenzel J, Furie R, Dall'Era M, Sanchez-Guerrero J, Roy S, Goodson SG, Moreau F, Gühring H, Sgouroudi E, Klopp-Schulze L, Pearson DR Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial , Lancet Rheumatol, 8(7): 2026,e513-e527
Dhiman R, Eldaboush A, Vijayarangan N, Kang D, Kodali N, Diaz D, Stone C, Feng R, Werth VP The Effects of CB2R Activation on Inflammatory Pathways in Dermatomyositis , Biomedicines, 14(6): 2026
Aggarwal R, Peeva E, Fiorentino DF, Vleugels RA, Mangold AR, Werth VP, Oemar BS, Rath JN, Sloan A, Chu M Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study , Clin Cosmet Investig Dermatol, 2026(19): 2026
